Cell Source, Inc.
Qualité des données : 83%
CLCS
OTC
Manufacturing
Chemicals
0,84 €
▲
0,06 €
(8,03%)
Cap. Boursière: 37,83 M
Prix
0,84 €
Cap. Boursière
37,83 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—
Quick Summary
Points Clés
Negative free cash flow of -2,68 M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROIC-873,75%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A
Valorisation
PE (TTM)
-8,38
En dessous de la moyenne du secteur (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1385 pairs)
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1385 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -8,4 | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -54,0 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
Aucune estimation prévisionnelle disponible
No quarterly estimates available
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -4,51 M |
| ROE | N/A | ROA | -1299,67% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -2,68 M |
| ROIC | -873,75% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | N/A |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | N/A | Tangible Book Value | -18,94 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -8,38 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -7,09% | ||
| Market Cap | 37,83 M | Enterprise Value | 37,83 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,14 | Revenue / Share | N/A |
| FCF / Share | -0,06 | OCF / Share | -0,06 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 59,48% |
| SBC-Adj. FCF | -2,99 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -4,51 M | -5,32 M | -5,17 M | -5,47 M | -4,56 M |
| EPS (Diluted) | -0,14 | -0,17 | -0,18 | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -3,84 M | -4,33 M | -4,18 M | -4,02 M | -3,64 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | 1,94 M | 1,27 M | 834 943,0 |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | 629 201,0 | 457 371,0 |
| Income Tax | — | — | — | — | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 286 500,0 | 195 171,0 | 409 845,0 | 313 767,0 | 452 339,0 |
| Total Liabilities | 18,82 M | 15,81 M | 13,04 M | — | 8,40 M |
| Shareholders' Equity | -18,54 M | -15,61 M | -12,63 M | -9,83 M | -7,95 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | — | — | 222 665,0 | 93 095,0 | 245 119,0 |
| Current Assets | — | — | — | 313 767,0 | — |
| Current Liabilities | — | — | — | 10,14 M | 8,40 M |
{"event":"ticker_viewed","properties":{"ticker":"CLCS","listing_kind":"stock","pathname":"/stocks/clcs","exchange":"OTC","country":"US"}}